HLB hits the lower price limit on FDA request for additional information; E-Mart target price cut (15%) and market close
HLB 2026year 7month 10day recorded the lower price limit during trading after the FDA requested additional information. During the same period, E-Mart's target price was cut based on weak Starbucks sales by 15%, while trading value related to Samsung Electronics and SK hynix, including leveraged products, accounted for 83% of the market.
HLB announced that it had been asked by the U.S. Food and Drug Administration (FDA) on 2026year 7month 10day to submit additional information related to its liver cancer drug. Immediately after the announcement, HLB shares recorded the lower price limit during trading.
According to the company, the FDA request concerns the submission of additional information on the drug. The specific submission deadline and scope should be confirmed in the disclosure document.
Along with the sharp decline in HLB shares, some biotechnology stocks weakened. The market focused on the possibility that the request for additional information could affect clinical and regulatory approval schedules.
Emart 2026year 7month 9day lowered its target price by citing weak Starbucks sales, 15%. The report stated that weak Starbucks performance had been reflected in retailers’ earnings forecasts.
Including leveraged products, the share of same-day trading value accounted for by stocks related to Samsung Electronics and SK hynix was tallied at 83%. Additional data is needed to determine whether the concentration of trading is temporary or persistent.
Samsung SDS announced that its target price had been raised after the visibility of its AI data center business was confirmed. The announcement was made by an investment research institution.
KT&G was assigned a target price of 220,000won, attracting attention for its interim dividend and shareholder return policy. The target price was presented based on a securities firm’s opinion.
Overall, during the day’s session, stocks related to biotechnology, retail, semiconductors, IT services, and dividends drew investor attention through trading and disclosures.